Related Experiment Video
Updated: May 22, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Tailored Adherence Incentives for Childhood Asthma Medications: A Randomized Clinical Trial
Chén C Kenyon1,2,3, William O Quarshie4, Rui Xiao3
1PolicyLab, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Financial incentives improved inhaled asthma medication adherence in children, but the effect faded after the intervention ended. This highlights the temporary impact of financial incentives on medication adherence.
Area of Science:
- Pediatric Health
- Clinical Trials
- Health Disparities
Background:
- Differential adherence to preventive medications contributes to racial disparities in childhood asthma.
- Targeting adherence is crucial for improving asthma outcomes in minority children.
Purpose of the Study:
- To assess the impact of a financial incentive-enhanced intervention on adherence to inhaled asthma preventive medication.
- To evaluate this intervention in a high-risk, predominantly racially minoritized pediatric cohort.
Main Methods:
- A randomized clinical trial involving children aged 5-12 with persistent asthma.
- Intervention included daily text reminders, weekly feedback, and financial incentives for medication adherence.
- Adherence was monitored using electronic inhaler sensors over a 7-month period (3-month intervention, 3-month observation).
Main Results:
- The full intervention group showed a 15-percentage point higher adherence compared to the active control group during the intervention period.
- No significant differences in adherence were observed between groups during the 3-month observation phase after the intervention ceased.
- The study included 106 children, with 82% identifying as non-Hispanic Black.
Conclusions:
- Financial incentive-enhanced mobile health interventions can temporarily improve inhaled preventive medication adherence in children.
- The positive effects on adherence did not persist after the intervention components were removed.
- Findings suggest that while incentives can boost adherence, their long-term impact requires further investigation.
Related Concept Videos
Inhaled Medications
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Asthma-IV: Nursing Management
First, in...

